Home Tech/AIIndustry & Trade Pfizer may outsource manufacturing some of its drugs to make way for coronavirus vaccine

Pfizer may outsource manufacturing some of its drugs to make way for coronavirus vaccine

by Amwal Al Ghad English
Avigan

Pfizer plans to outsource production of some of its drug portfolio to make way for a rapidly growing vaccine manufacturing effort, the company said Monday.

The drugmaker will lean on its 200-strong network of contractors as part of a plan to “build a robust U.S.-based supply chain as well as one based in Europe,” a Pfizer spokesperson said.

Pfizer has dedicated enormous resources to churning out hundreds of millions of doses of a possible coronavirus vaccine.

The drugmaker will lean on its 200-strong network of contractors as part of a plan to “build a robust U.S.-based supply chain as well as one based in Europe,” a Pfizer spokesperson said.

You may also like

Leave a Comment